Novel Gene Therapy Viral Vector Using Non-Oncogenic Lymphotropic Herpesvirus

Despite the use of retroviral vectors, efficiently introducing target genes into immunocytes such as T cells is difficult. In addition, retroviral vectors carry risks associated with the oncogenicity of the native virus and the potential for introducing malignancy in recipients due to genetic carryo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Akihiro, Kobayashi, Nobuyuki, Shimada, Kazuya, Oura, Kuniaki, Tanaka, Tadao, Okamoto, Aikou, Kondo, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569415/
https://www.ncbi.nlm.nih.gov/pubmed/23409116
http://dx.doi.org/10.1371/journal.pone.0056027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569415/
https://www.ncbi.nlm.nih.gov/pubmed/23409116
http://dx.doi.org/10.1371/journal.pone.0056027

Ejemplares similares